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Abstract
Background  and  objectives: Laryngoscopy  and  intubation  can  cause  hemodynamic  response.
Various medications  may  be  employed  to  control  that  response.  In  this  study,  we  aimed  to
compare  the  effects  of  dexmedetomidine,  fentanyl  and  esmolol  on  hemodynamic  response.
Methods:  Ninety  elective  surgery  patients  who  needed  endotracheal  intubation  who  were  in
American  Society  of  Anesthesiology  I--II  group  and  ages  between  21  and  65  years  were  included  in
that  prospective,  randomized,  double-blind  study.  Systolic,  diastolic,  mean  arterial  pressures,
heart  rates  at  the  time  of  admittance  at  operation  room  were  recorded  as  basal  measure-
ments. The  patients  were  randomized  into  three  groups:  Group  I  (n  =  30)  received  1  g/kg
dexmedetomidine  with  infusion  in  10  min,  Group  II  (n  =  30)  received  2  g/kg  fentanyl,  Group
III  received  2  mg/kg  esmolol  2  min  before  induction.  The  patients  were  intubated  in  3  min.  Sys-
tolic,  diastolic,  mean  arterial  pressures  and  heart  rates  were  measured  before  induction,  before
intubation  and  1,  3,  5,  10  min  after  intubation.
Results: When  basal  levels  were  compared  with  the  measurements  of  the  groups,  it  was  found
that 5  and  10  min  after  intubation  heart  rate  in  Group  I and  systolic,  diastolic,  mean  arterial
pressures  in  Group  III  were  lower  than  other  measurements  (p  <  0.05).
Conclusions: Dexmedetomidine  was  superior  in  the  prevention  of  tachycardia.  Esmolol  pre-
vented sytolic,  diastolic,  mean  arterial  pressure  increases  following  intubation.  We  concluded
that  further  studies  are  needed  in  order  to  ﬁnd  a  strategy  that  prevents  the  increase  in  systemic
blood  pressure  and  heart  rate  both.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Esmolol
Comparac¸ão  entre  os  efeitos  de  dexmedetomidina,  fentanil  e  esmolol  na  prevenc¸ão
da  resposta  hemodinâmica  à  intubac¸ão
Resumo
Justiﬁcativa  e  objetivos:  Laringoscopia  e  intubac¸ão  podem  causar  resposta  hemodinâmica.
Vários  medicamentos  podem  ser  usados  para  controlar  essa  resposta.  Neste  estudo,  nosso
objetivo  foi  comparar  os  efeitos  de  dexmedetomidina,  fentanil  e  esmolol  sobre  a  resposta
hemodinâmica.
Métodos:  Foram  incluídos  no  estudo  prospectivo,  randômico  e  duplo-cego  90  pacientes  progra-
mados  para  cirurgias  eletivas,  com  intubac¸ão  endotraqueal,  estado  físico  ASA  I-II,  entre  21  e  65
anos.  Pressões  arteriais  médias,  sistólicas,  diastólicas  e  frequências  cardíacas  foram  medidas  ao
darem  entrada  na  sala  de  operac¸ões  e  registradas  como  valores  basais.  Os  pacientes  foram  ran-
domizados  em  três  grupos:  Grupo  I  (n  =  30)  recebeu  1  g/kg  de  dexmedetomidina  com  infusão
em  10  min;  Grupo  II  (n  =  30)  recebeu  2  g/kg  de  fentanil;  Grupo  III  (n  =  30)  recebeu  2  mg/kg  de
esmolol  2  min  antes  da  induc¸ão.  Os  pacientes  foram  intubados  em  3  min.  As  pressões  médias,
sistólicas  e  diastólicas  e  as  frequências  cardíacas  foram  medidas  antes  da  induc¸ão,  antes  da
intubac¸ão  e  nos  minutos  1,  3,  5  e  10  após  a  intubac¸ão.
Resultados:  Quando  os  níveis  basais  foram  comparados  entre  os  grupos,  veriﬁcou-se  que  nos
minutos 5  e  10  pós-intubac¸ão  as  frequências  cardíacas  no  Grupo  I  e  as  pressões  arteriais  médias,
sistólicas  e  diastólicas  no  Grupo  III  estavam  mais  baixas  do  que  em  outros  tempos  mensurados
(p  <0,05  ).
Conclusões:  Dexmedetomidina  foi  superior  na  prevenc¸ão  de  taquicardia.  Esmolol  preveniu  o
aumento  das  pressões  arteriais  médias,  sistólicas  e  diastólicas  após  a  intubac¸ão.  Concluímos  que
estudos  adicionais  são  necessários  para  descobrir  uma  estratégia  que  previna  tanto  o  aumento
da  pressão  arterial  sistêmica  quanto  da  frequência  cardíaca.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
During  general  anesthesia  airway  control  is  generally
provided by  laryngoscopy  and  intubation.  Laryngoscopy
and intubation  lead  to  mechanical  and  chemical  stimuli.
Mechanical stimulus  causes  reﬂex  responses  in  cardiovas-
cular and  respiratory  systems.1 That  response  reaches  its
maximum level  within  1  min  and  ends  in  5--10  min  after
intubation. On  the  other  hand,  chemical  stimulus  results
with catecholamine  release  via  increase  in  sympathoadren-
ergic activity.  Catecholamine  release  leads  to  hypertension,
tachycardia and  arrhythmia.  Tachycardia  generates  a  more
powerful load  on  the  heart  when  compared  with  hyperten-
sion as  it  increases  oxygen  consumption  of  the  myocardium,
decreases diastolic  ﬁlling  and  ﬁnally  reduces  coronary  blood
supply.2
The  degree  of  the  reﬂex  response  of  laryngoscopy  and
intubation is  related  with  the  deepness  of  anesthesia,
patient’s age  and  the  presence  of  diabetes  or  heart  disease.
Narcotic analgesics,  local  anesthetics,  beta-blockers,  cal-
cium canal  blockers  and  vasodilators  are  employed  in  order
to control  that  response.3 Dexmedetomidine  is  a  selective
2 adrenergic  agonist.  Its  effects  on  cardiovascular  sys-
tem are  particularly  prominent.4,5 The  effect  of  fentanyl
on cardiovascular  system  is  not  much.  The  exact  reason
of bradycardia  due  to  fentanyl  use  is  not  clear,  but  it  is
considered to  be  related  with  central  vagal  stimulation.6
Among  these  agents,  esmolol  is  a  cardioselective    adren-
ergic blocker  that  has  an  effect  with  rapid  onset  and  short
duration. While  it  inhibits  1 receptors  of  myocardium,  it
m
C
r
ilso  inhibits  2 receptors  of  smooth  muscles  of  bronchial
nd vascular  walls  at  higher  doses.7
In  this  study,  we  aimed  to  compare  the  effects  of
exmedetomidine,  fentanyl  and  esmolol  on  control  of  hemo-
ynamic response  due  to  laryngoscopy  and  intubation.
ethods
he  study  was  approved  by  Ethical  Board  of  Ankara  Numune
raining and  Research  Hospital.  Ninety  elective  surgery
atients who  were  in  American  Society  of  Anesthesiol-
gy (ASA)  I and  II  groups  and  whose  ages  were  between
1 and  65  years  were  included  in  that  study.  The  study
as planned  as  a  prospective,  double  blind  and  random-
zed study.  Those  in  whom  difﬁculty  in  intubation  was
xpected, who  had  coronary  artery  disease,  hyperten-
ion, chronic  obstructive  pulmonary  disease  or  diabetes
nd who  were  using  any  cardiovascular  medication  were
xcluded.
All patients  were  examined  one  day  before  and  their  lab-
ratory results  were  reviewed.  Included  patients  received
ecessary information  about  the  study  and  gave  their
ritten consents.  Before  admittance  to  operation  room,
ascular access  was  obtained  from  the  back  of  the  hand
ith 20G  canula  and  10  mL/kg/hour  Ringer’s  lactate  infusion
as started.  Following  transferring  to  operation  room,  pre-
edication with  0.01  mg/kg  iv  midazolam  was  performed.
AMS II  (Comprehensive  Anesthesia  Monitor)  was  used  for
outine monitorization;  ECG  and  heart  rate  (HR)  were  mon-
tored at  standard  DII  derivation;  systolic  (SAP),  diastolic
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Table  1  Patient  demographics  in  the  groups.
Group  I  (n  =  30)  Group  II  (n  =  30)  Group  III  (n  =  30)
Age  (years)  41.2  ±  10.6  41.5  ±  10.0  43.8  ±  12.8
Gender  (F/M)  11/19  15/15  15/15
ASA (I/II)  15/15  11/19  15/15
Weight (kg)  77.9  ±  11.0  75.5  ±  12.6  77.0  ±  12.3
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pDAP)  and  mean  (MAP)  arterial  pressures  were  monitored  via
utomatic non-invasive  blood  pressure  measurements  and
eripheral oxygen  saturation  (SpO2)  was  monitored  via  pulse
xymetry.
The patients  were  randomized  into  three  groups.  These
roups were  determined  with  closed  envelopes.  The
ubjects were  blinded  to  the  treatment  they  received.
he anesthesiologists  who  prepared  and  administered
he medications  were  provided  to  be  different.  Group  I
n =  30)  received  1  g/kg  dexmedetomidine  (Precedex®,
editera, 200  g/2  mL)  with  infusion  in  10  min,  Group
I (n  =  30)  received  2  g/kg  fentanyl  citrate  (Fentanyl®,
anssen-Cilag, 0.05  mg/mL)  and  Group  III  received  2  mg/kg
smolol (Brevibloc®,  Eczacibasi,  10  mg/mL)  2  min  before
nduction. Then  6  mg/kg  thiopental  and  0.1  mg/kg  vecuro-
ium were  administered  intravenously.  Three  minutes
ater laryngoscopy  and  intubation  were  performed  by  the
ame anesthesiologist.  The  patients  in  whom  endotracheal
ntubation could  not  be  achieved  within  45  s  were  excluded
rom the  study.  All  patients  received  50%O2 (2  L/min),  50%
2O  (2  L/min)  and  1.5  MAC  sevoﬂurane  (Sevorane®,  Abbott)
uring maintenance  of  anesthesia.  These  parameters
ere measured  and  recorded  before  induction  (t0),  after
nduction (t1)  before  intubation  (t2)  and  1  (t3),  3(t4),  5
t5)  and  10  min  (t6)  after  intubation  in  all  patients.  The
easurements before  induction  (t0)  were  considered  as
asal levels  and  all  of  other  measurements  were  compared
ith these  basal  levels.  Surgical  incisions  were  started
ollowing completion  of  that  data  collection  process.  The
atients were  ventilated  in  order  to  maintain  end  tidal  CO2
evels  between  30  and  35  mm  Hg.  During  the  operations
R, SAP,  MAP,  DAP,  and  SpO2 levels  were  recorded  with
 min  intervals.  After  the  operations,  the  subjects  were
onitored in  recovery  room  for  60  min  following  awakening
nd then  were  transferred  to  inpatient  clinics.
p
(
p
Table  2  The  comparison  of  the  groups  according  to  systolic  arter
Group  I  (n  =  30)  Group  II  (n  =  
t0 138.63  ±  16.99  141.03  ±  11.
t1 117.00  ±  18.27a 123.73  ±  17.
t2 115.37  ±  18.47a 132.83  ±  17.
t3 147.13  ±  19.41  156.60  ±  16.
t4 129.20  ±  20.72  134.63  ±  16.
t5 119.17  ±  17.10a 116.67  ±  17.
t6 116.17  ±  17.01a 110.73  ±  18.
a Extremely signiﬁcant at the level of p < 0.001 (inter group comparis
b Signiﬁcant at the level of p < 0.05.tatistical  analysis
PSS  (Statistical  Package  for  Social  Sciences)  for  Windows
ersion 10.0  was  used  for  statistical  analysis.  One-way  Anova
nd  Student’s  t  test  were  used  for  comparison  of  quanti-
ative data  besides  descriptive  statistical  methods  (mean,
tandard deviation)  in  evaluation  of  study  data.  Chi-square
est was  employed  for  comparison  of  qualitative  data.  The
omparisons were  considered  as  not  signiﬁcant  (p  >  0.05),
igniﬁcant (p  <  0.05)  or  extremely  signiﬁcant  (p  <  0.001)  in
 conﬁdence  interval  of  95%.  A  sample  size  of  30  achieved
00% power  to  detect  a  difference  (P1--P0)  of  0.2540  using
 two-sided  binomial  test.  The  target  signiﬁcance  level  was
.0500. The  actual  signiﬁcance  level  achieved  by  this  test
as 0.9229  (92%).
esults
here  was  no  difference  between  three  groups  according  to
ge, weight,  gender  and  ASA  physiological  scores  (p  >  0.05
or all,  Table  1).
Mean SAP  decreased  at  t1,  t2, t5,  and  t6 in  Group  I,  at  t1,
5 and  t6 in  Group  II,  at  t2,  t5,  and  t6 in  Group  III  (p  <  0.001
or all).  When  the  groups  were  compared  with  eachother,
ean SAP  was  lower  in  Group  III  than  other  groups  at  t1,  t2,
5 and  t6 (p  <  0.05  for  all,  Table  2).
Mean  DAP  decreased  at  t1,  t2, and  t6 in  Group  I  (p  <  0.001,
 < 0.001  and  p  <  0.05,  respectively),  at  t5 and  t6 in  Group  II
p <  0.001for  both),  at  t1, t2, t5,  and  t6 in  Group  III  (p  < 0.05,
 < 0.001,  p  <  0.05  and  p  <  0.001,  respectively,  Table  3).
Mean  MAP  decreased  at  t1,  t2, and  t6 in  Group  I  (p  <  0.001,
 < 0.001and  p  <  0.05,  respectively),  at  t5 and  t6 in  Group  II
p <  0.001for  both),  at  t1, t2,  t5 and  t6 in  Group  III  (p  <  0.05,
 < 0.001,  p  <  0.05  and  p  <  0.001,  respectively).  When  the
y  pressure  measurements  (mm  Hg).
30)  Group  III  (n  =  30)  p
87  131.03  ±  16.55  0.066
45a 114.27  ±  20.81  0.040b
76  103.07  ±  17.45a 0.039b
87  147.43  ±  21.27  0.079
46  125.93  ±  23.70  0.055
43a 111.60  ±  19.91a 0.037b
05a 103.90  ±  22.06a 0.031b
ons).
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Table  3  The  comparison  of  the  groups  according  to  diastolic  artery  pressure  measurements  (mm  Hg).
Group  I  (n  =  30) Group II  (n  =  30)  Group  III  (n  =  30)  p
t0 82.03  ±  10.23  82.67  ±  9.87  80.57  ±  10.26  0.055
t1 73.33  ±  12.07a 80.40  ±  9.11  71.03  ±  14.89a 0.040b
t2 72.00  ±  13.40c 83.57  ±  11.93  63.73  ±  11.20c 0.038b
t3 97.73  ±  12.28  99.23  ±  13.01  95.07  ±  13.49  0.080
t4 83.07  ±  14.40 88.50  ±  13.97  80.83  ±  14.68  0.058
t5 76.77  ±  12.15 75.10  ±  12.34 71.67  ±  15.61a 0.040b
t6 74.90  ±  13.60 73.50  ±  12.16a 67.76  ±  16.62c 0.035b
a Signiﬁcant at the level of p < 0.05 (inter group comparisons).
b Signiﬁcant at the level of p < 0.05.
c Extremely signiﬁcant at the level of p < 0.001 (inter group comparisons).
Table  4  The  comparison  of  the  groups  according  to  mean  artery  pressure  measurements  (mm  Hg).
Group  I  (n  =  30)  Group  II  (n  =  30)  Group  III  (n  =  30)  p
t0 100.77  ±  12.23  99.97  ±  11.81  96.43  ±  11.66  0.058
t1 87.10  ±  12.05a 95.60  ±  10.55  84.10  ±  16.43b 0.040c
t2 86.63  ±  14.14a 121.63  ±  17.76  76.83  ±  13.02a 0.037c
t3 114.30  ±  13.65  119.53  ±  16.87  112.33  ±  19.49  0.081
t4 98.63  ±  15.22  102.30  ±  16.46  97.13  ±  16.85  0.056
t5 91.90  ±  13.15  84.80  ±  17.43a 85.63  ±  16.88b 0.039c
t6 90.30  ±  14.38b 85.73  ±  18.05a 80.86  ±  20.35a 0.035c
a Extremely signiﬁcant at the level of p < 0.001 (inter group comparisons).
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aSigniﬁcant at the level of p < 0.05 (inter group comparisons).
c Signiﬁcant at the level of p < 0.05.
groups  were  compared  with  eachother,  mean  MAP  was  lower
in Group  III  than  other  groups  at  t1,  t2,  t5 and  t6 (p  <  0.05  for
all, Table  4).
Mean HR  decreased  at  t1,  t2,  t4,  t5 and  t6 in  Group  I
(p <  0.001for  all)  at  t2,  t5 and  t6 in  Group  II  (p  <  0.001,  p  <  0.05
and p  <  0.001,  respectively)  and  at  t2 and  t6 in  Group  III
(p <  0.05  for  both).  When  the  groups  were  compared  with
eachother, mean  HR  was  lower  in  Group  I  than  other  groups
at t1,  t2,  t5 and  t6 (p  <  0.001  for  all,  Table  5).Discussion
Pathophysiologic  effects  of  endotracheal  intubation  may
be encountered  almost  in  all  systems  of  the  body  and
g
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Table  5  The  comparison  of  the  groups  according  to  heart  rate  m
Group  I  (n  =  30)  Group  II  (n  =  3
t0 87.7  ±  13.35  90.97  ±  17.40
t1 73.47  ±  6.9a 87.57  ±  14.17
t2 69.23  ±  8.19a 79.60  ±  15.16
t3 82.27  ±  8.25  93.20  ±  12.54
t4 76.17  ±  9.18a 87.53  ±  14.47
t5 70.17  ±  14.8a 80.00  ±  13.44
t6 70.60  ±  9.03a 75.72  ±  12.50
a Extremely signiﬁcant at the level of p < 0.001 (inter group comparis
b Extremely signiﬁcant at the level of p < 0.001.
c Signiﬁcant at the level of p < 0.05 (inter group comparisons).ay  lead  to  harmful  consequences.  The  most  frequent
ffects are  cardiovascular  hemodynamic  responses  char-
cterized with  hypertension,  tachycardia,  arrhythmia  and
ncrease in  sympathoadrenergic  activity.  Although  cardio-
ascular hemodynamic  responses  carry  risk  for  all  patients
ho receive  anesthesia  that  risk  is  more  prominent  in
hose who  have  cerebrovascular  or  coronary  artery  dis-
ase. Thus  preventing  the  increase  in  sympathoadrenergic
ctivity due  to  endotracheal  intubation  is  an  important
spect.8 Dexmedetomidine  that  is  a  selective  2 adrener-
ic agonist,  fentanyl  that  is  an  opioid  and  esmolol,  that
s a    adrenergic  receptor  blocker  are  generally  used  for
hat purpose.  When  we  compared  these  medications  with
ach other,  we  observed  that  dexmedetomidine  controlled
easurements  (beat/min).
0)  Group  III  (n  =  30)  p
 86.34  ±  11.49  0.062
 82.00  ±  11.49  0.0048b
a 78.10  ±  9.49c 0.0035b
 89.38  ±  10.6  0.066
 89.55  ±  10.8  0.0569
c 84.48  ±  10.00  0.004b
a 79.38  ±  11.005c 0.003b
ons).
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eart  rate  and  esmolol  controlled  blood  pressure  bet-
er.
Gupta et  al.6 compared  the  effects  of  2  mg/kg  esmolol
nd 2  g/kg  fentanyl  that  were  administered  3  min  before
nesthesia induction  in  order  to  prevent  hemodynamic
esponse in  patients  in  whom  elective  surgical  procedures
ere planned.  They  reported  that  a  single  dose  of  esmolol
revented the  increase  in  blood  pressure.  They  also  found
hat, although  clinically  insigniﬁcant,  the  effect  of  esmolol
n the  increase  in  heart  rate  was  better  than  fentanyl.
tlee et  al.9 compared  the  effects  of  1  mg/kg  esmolol  and
0 g/kg  nicardipine  alone  and  in  combination  and  reported
hat they  did  not  prevent  blood  pressure  change  when  they
ere administered  solely,  but  were  effective  in  combina-
ion. These  drugs  did  not  show  any  effect  on  heart  rate
lone or  in  combination.  Figueredo  et  al.10 performed  a
eta-analysis of  different  esmolol  doses  and  reported  that
nfusion was  more  effective  than  single  dose  administration
o prevent  cardiovascular  stress  response.  We  used  esmolol
t a  dose  of  2  mg/kg  in  this  study.  We  observed  that  this  level
as adequate  to  prevent  the  increases  in  systolic,  diastolic
nd mean  arterial  pressures,  but  did  not  have  any  effect  on
eart rate.
Adachi et  al.11 used  2  g/kg  fentanyl  just  before  induc-
ion in  order  to  prevent  cardiovascular  stress.  They  found
hat fentanyl  was  more  effective  in  prevention  of  cardio-
ascular hemodynamic  response  secondary  to  endotracheal
ntubation than  prevention  of  hemodynamic  response  to
aryngoscopy. They  reported  that  this  effect  of  fentanyl
as related  with  the  interaction  with  plasma  concentra-
ions of  the  anesthetics  that  were  used  for  induction.
gur et  al.12 used  1.5  mg/kg  esmolol,  1  g/kg  fentanyl
nd 1.5  mg/kg  lidocain  2  min  before  intubation  and  found
hat esmolol  prevented  the  increase  in  heart  rate.  On
he other  hand,  Hussain  et  al.7 compared  the  effects  of
 g/kg  fentanyl  and  2  mg/kg  esmolol  that  were  admin-
stered 2  min  before  laryngoscopy  and  intubation  and
eported that  fentanyl  was  inadequate  to  prevent  the
ncreases in  heart  rate  and  blood  pressure.  They  also
howed that  esmolol  prevented  the  increase  in  heart  rate,
ut did  not  have  any  effect  on  blood  pressure.  In  our
tudy, we  found  that  2  mg/kg  esmolol  decreased  systolic,
iastolic and  mean  arterial  pressures  more  than  2  g/kg
entanyl, but  there  was  not  any  difference  between  two
roups according  to  prevention  of  the  increase  in  heart
ate.
Dexmedetomidine decreases  arterial  blood  pressure  and
eart rate  by  reducing  serum  noradrenalin  levels.  Talke
l al.13 performed  a  placebo  controlled  study  in  vascu-
ar surgery  and  showed  that  dexmedetomidine  caused  less
ncrease in  heart  rates  and  noradrenalin  levels  when  admin-
stered at  a  dose  of  0.8  g/kg  via  intravenous  infusion.
all et  al.14 used  0.2  and  0.6  g/kg  dexmedetomidine
ia intravenous  infusion  and  reported  that  although  heart
ate decreased  prominently,  there  was  not  any  change
n mean  arterial  pressure.  Similarly,  Yildiz  et  al.15 found
hat a  single  dose  of  1  g/kg  dexmedetomidine  prevented
ardiovascular hemodynamic  response  and  decreased  the
eed for  additional  opioid  during  laryngoscopy  and  endo-
racheal intubation  in  elective  minor  surgery  patients.
t was  noticed  that  infusion  doses  of  dexmedetomidine
sed in  these  studies  were  between  0.2  and  0.8  g/kg.N.  Gogus  et  al.
lternatively,  Ozkose  et  al.16 administered  a  single  dose
f 1  g/kg  dexmedetomidine  10  min  before  induction.  They
eported that  when  compared  with  control  measurements,
ean arterial  pressures  decreased  up  to  20%  and  heart  rates
ecreased up  to  15%  1  and  3  min  following  intubation.  They
bserved bradycardia  that  necessitated  atropin  administra-
ion in  four  of  their  20  patients.  We  administered  1  g/kg
exmedetomidine before  induction  via  infusion  in  10  min.
e did  not  demonstrate  any  difference  in  systolic,  diastolic
nd mean  arterial  pressures  between  groups,  but  found  that
t was  effective  in  preventing  the  increase  in  heart  rate.
The  most  common  side  effects  of  dexmedetomidine  are
ypotension and  bradycardia  that  occur  more  frequently
uring loading  period.  We  suggest  that  reducing  loading
ose and  slowing  infusion  rate  may  prevent  cardiovascu-
ar side  effects.  We  administered  dexmedetomidine  with
low infusion  in  our  study  and  observed  bradycardia  neces-
itating atropin  use  in  only  one  of  our  patients.  Similarly
enn et  al.17 reported  that  these  side  effects  were  not
bserved when  2.5  g/kg  loading  dose  of  dexmedetomidine
as administered  in  10  min  and  followed  by  an  infusion  rate
f 0.2--0.5  g/kg/min.
We concluded  that  esmolol  was  more  effective  than
exmedetomidine and  fentanyl  in  prevention  of  the
ncreases in  systolic,  diastolic  and  mean  arterial  pressures
ollowing endotracheal  intubation.  On  the  other  hand,
exmedetomidine was  more  effective  than  esmolol  and  fen-
anyl in  preventing  the  increase  in  heart  rate.  To  prevent
he increases  in  blood  pressure  and  heart  rate  is  partic-
larly important  from  the  aspect  of  myocardial  ischemia.
e considered  that  further  studies  will  be  suitable  in  which
hese agents  are  used  in  combination  in  order  to  prevent  the
ncrease in  systemic  blood  pressure  and  heart  rate  both.
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